Cleared Traditional

K221080 - Sterile Safety Hypodermic Needles for S...

K221080 is an FDA 510(k) clearance for Sterile Safety Hypodermic Needles for S..., manufactured by Sichuan Prius Biotechnology Co., Ltd.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 175-day FDA review.

K221080 · Sichuan Prius Biotechnology Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
175d
Days
Class 2
Risk

K221080 is an FDA 510(k) clearance for the Sterile Safety Hypodermic Needles for Single Use. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Sichuan Prius Biotechnology Co., Ltd. (Yibin, CN). The FDA issued a Cleared decision on October 4, 2022 after a review of 175 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sichuan Prius Biotechnology Co., Ltd. devices

FDA 510(k) Submission Details - K221080

510(k) Number K221080 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2022
Decision Date October 04, 2022
Days to Decision 175 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d slower than avg
Panel avg: 129d · This submission: 175d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 271
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K221080.
IO Needle Safety Sheath
K220890 · Actuated Medical, Inc. · Oct 2022
Safety Insulin Pen Needles
K213183 · Zhejiang Kindly Medical Devices Co., Ltd. · Oct 2022
Sterile Hypodermic Needles for Single Use
K221066 · Sichuan Prius Biotechnology Co., Ltd. · Oct 2022
Promisemed X-Safety Pen Needle
K220129 · Promisemed Hangzhou Meditech Co., Ltd. · Sep 2022
Disposable Medical Safety Hypodermic Needle
K220603 · Hantech Medical Device Co., Ltd. · Aug 2022
SurGuard3 Safety Hypodermic Needle
K212095 · Terumo Europe N.V. · Aug 2022